Value proposition

LexaGene’s MiQLab® System—automated, rapid pathogen detection point of care for veterinary diagnostics and other mkts.

LexaGene (OTCQB:LXXGF - TSX.V:LXG) is a molecular diagnostics company developing an open-access, fully automated system for rapid and sensitive pathogen detection. Our MiQLab® System is PCR-based instrument that can detect up to 27 targets at once for testing in human clinical and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.

Molecular Diagnostics, Veterinary Diagnostics, Human Clinical Diagnostics, Open-access Testing, Food Safety Testing, and Pathogen Detection